Document is current
Any future updates will be listed below
-
Authors
Bahat, Gulistan https://orcid.org/0000-0001-5343-9795
Catikkas, Nezahat Muge https://orcid.org/0000-0003-2494-1625
Karan, Mehmet Akif https://orcid.org/0000-0002-9080-404X
Reginster, Jean Yves https://orcid.org/0000-0001-6290-752X
- License Information
-
More Information
Article History
Received: 2 April 2021
Accepted: 14 June 2021
First Online: 26 June 2021
Declarations
:
: Gulistan Bahat has received a speaker honorarium from the companies LILLY and AMGEN. Nezahat Muge Catikkas has no conflicts of interest to declare that are relevant to the content of this article. Mehmet Akif Karan has no conflicts of interest to declare that are relevant to the content of this article. Jean Yves Reginster has received consulting fees or paid advisory boards from these companies: IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Farma, Rejuvenate Biomed, Samumed, Teva, Theramex, Pfizer, and Mithra Pharmaceuticals. He has received lecture fees when speaking at the invitation of sponsors from these companies: IBSA-Genevrier, Mylan, CNIEL, Dairy Research Council (DRC), Nutricia, Danone, and AgNovos. He also has received grant support from industry (all through institution): IBSA-Genevrier, Mylan, CNIEL, Radius Health, and TRB.
